FMS - רווח לפני ניכוי ריבית, מסים, בלאי ופחת Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care generates revenue from dialysis services and equipment, relying on insurance fund payments. The nursing shortage remains a challenge, although the administrative staff remains stable. Management is currently seeking to improve profitability by closing inefficient centers. The EBITDA_Co metric reflects actual cash flow, with the value recorded at 4200.92, allowing for a real-time assessment of the business's current operational resilience.

Evaluating real cash flow is critical when selecting defensive assets with minimal risk. This indicator captures earnings before interest and taxes, reflecting the net efficiency of operating activities. For the dialysis monopolist Fresenius Medical Care (FMS), this allows for tracking the impact of labor shortages on service pricing. An analysis of EBITDA trends reveals a hidden compression of margins across the entire value chain.